Dynatrace (DT) reported $493.85 million in revenue for the quarter ended September 2025, representing a year-over-year increase of 18.1%. EPS of $0.44 for the same period compares to $0.37 a year ago.
The reported revenue represents a surprise of +1.35% over the Zacks Consensus Estimate of $487.26 million. With the consensus EPS estimate being $0.41, the EPS surprise was +7.32%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Dynatrace performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Annual Recurring Revenue (ARR)- Total: $1.9 billion versus the nine-analyst average estimate of $1.87 billion.
- Revenues- Services: $20.76 million versus $20.27 million estimated by 10 analysts on average. Compared to the year-ago quarter, this number represents a +13.3% change.
- Revenues- Subscriptions: $473.09 million versus the 10-analyst average estimate of $467.02 million. The reported number represents a year-over-year change of +18.3%.
View all Key Company Metrics for Dynatrace here>>>
Shares of Dynatrace have returned +3.1% over the past month versus the Zacks S&P 500 composite's +1% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Dynatrace, Inc. (DT): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
